Rubicon Genomics Inc. announced that it has partnered with additional distributors to expand availability of its DNA library preparation products, including its ThruPLEX-FD Prep Kits and PicoPLEX DNA-seq Kits for use with Illumina next-generation sequencing systems.
Ann Arbor-based Rubicon Genomics Inc. has reported a surge in sales of its DNA analysis technology, with sales growth of 85 to 90 percent from 2012 to 2013 — the fourth straight year of strong growth.
Rubicon Genomics Inc. Thursday announced new distributors in Europe and Asia for its kits that allow laboratories to conduct sophisticated DNA tests with very small samples.
Ann Arbor-based Rubicon Genomics Inc. said its ThruPlex-FD prep kits contributed to the success of a study published in Nature that showed that genomic data extracted from the plasma of cancer patients can be used to track drug resistance and potentially guide treatment.
Rubicon Genomics Inc. announced Tuesday that its NovaPlex family of sample preparation technologies is increasing the feasibility and utility of molecular diagnostic testing and helping to address the shortage of patient samples that is hampering new drug discovery and the development of personalized medicine.
Rubicon Genomics Inc. Wednesday announced the launch of the first product in its innovative ThruPlex family of sample preparation kits designed and optimized for next generation sequencing.
Rubicon Genomics Inc. said Thursday it had signed a supply agreement with Durham, N.C.-based Kreatech Diagnostics for the use of its whole genome amplification technology.
Rubicon Genomics Inc. said Friday it had selected Plymouth-based Velesco Pharmaceutical Services to manufacture the TransPlex RNA amplification kits it will be supplying for breast cancer diagnostics manufactured by Agendia.
Ann Arbor-based Rubicon Genomics Inc. said Thursday that it had a new clinical supply agreement with the Amsterdam, Netherlands-based diagnostics firm Agendia.
New England Biolabs Inc. and Ann Arbor-based Rubicon Genomics said Tuesday that they have signed a distribution agreement whereby NEB will distribute a product that uses Rubicon’s proprietary amplification technology to enable the amplification of DNA from single cells or extremely low amounts of input DNA.